182 related articles for article (PubMed ID: 8292253)
1. An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity.
Navarro M; Fernández-Ruiz JJ; de Miguel R; Hernández ML; Cebeira M; Ramos JA
Behav Brain Res; 1993 Oct; 57(1):37-46. PubMed ID: 8292253
[TBL] [Abstract][Full Text] [Related]
2. Motor disturbances induced by an acute dose of delta 9-tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergic alterations.
Navarro M; Fernández-Ruiz JJ; De Miguel R; Hernández ML; Cebeira M; Ramos JA
Pharmacol Biochem Behav; 1993 Jun; 45(2):291-8. PubMed ID: 8392200
[TBL] [Abstract][Full Text] [Related]
3. delta 9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens.
Bonnin A; Fernández-Ruiz JJ; Martín M; Rodríguez de Fonseca F; Hernández ML; Ramos JA
J Neural Transm Gen Sect; 1993; 92(2-3):81-95. PubMed ID: 8103663
[TBL] [Abstract][Full Text] [Related]
4. Perinatal delta 9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs.
García L; de Miguel R; Ramos JA; Fernàndez-Ruiz JJ
Drug Alcohol Depend; 1996 Nov; 42(3):155-66. PubMed ID: 8912798
[TBL] [Abstract][Full Text] [Related]
5. Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats.
Navarro M; de Miguel R; Rodríguez de Fonseca F; Ramos JA; Fernández-Ruiz JJ
Behav Brain Res; 1996 Feb; 75(1-2):91-8. PubMed ID: 8800663
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas.
Rodríguez De Fonseca F; Fernández-Ruiz JJ; Murphy LL; Cebeira M; Steger RW; Bartke A; Ramos JA
Pharmacol Biochem Behav; 1992 Jun; 42(2):269-75. PubMed ID: 1321451
[TBL] [Abstract][Full Text] [Related]
7. Modifications of mesolimbic and nigrostriatal dopaminergic activities after intracerebroventricular administration of prolactin.
Hernández ML; Fernández-Ruiz JJ; Navarro M; de Miguel R; Cebeira M; Vaticón L; Ramos JA
J Neural Transm Gen Sect; 1994; 96(1):63-79. PubMed ID: 7857592
[TBL] [Abstract][Full Text] [Related]
8. Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids.
Navarro M; Rodríguez de Fonseca F; Hernández ML; Ramos JA; Fernández-Ruiz JJ
Pharmacol Biochem Behav; 1994 Jan; 47(1):47-58. PubMed ID: 7906890
[TBL] [Abstract][Full Text] [Related]
9. The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons.
Romero J; García L; Cebeira M; Zadrozny D; Fernández-Ruiz JJ; Ramos JA
Life Sci; 1995; 56(23-24):2033-40. PubMed ID: 7776829
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment.
Rodríguez de Fonseca F; Gorriti MA; Fernández-Ruiz JJ; Palomo T; Ramos JA
Pharmacol Biochem Behav; 1994 Jan; 47(1):33-40. PubMed ID: 8115426
[TBL] [Abstract][Full Text] [Related]
11. Perinatal delta(9)-tetrahydrocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons to dopamine-acting drugs in adult rats.
García-Gil L; De Miguel R; Muñoz RM; Cebeira M; Villanua MA; Ramos JA; Fernández-Ruiz JJ
Neurotoxicol Teratol; 1997; 19(6):477-87. PubMed ID: 9392783
[TBL] [Abstract][Full Text] [Related]
12. Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function.
Romero J; de Miguel R; García-Palomero E; Fernández-Ruiz JJ; Ramos JA
Brain Res; 1995 Oct; 694(1-2):223-32. PubMed ID: 8974649
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of chronic treatment with either dopamine D1 or D2 receptor agonists on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats.
Rodríguez de Fonseca FR; Villanúa MA; Muñoz RM; San-Martin-Clark O; Navarro M
Neuroendocrinology; 1995 Jun; 61(6):714-21. PubMed ID: 7659195
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of delta 9-tetrahydrocannabinol on tuberoinfundibular dopamine activity, anterior pituitary sensitivity to dopamine and prolactin release vary as a function of estrous cycle.
Bonnin A; Ramos JA; Rodríguez de Fonseca F; Cebeira M; Fernández-Ruiz JJ
Neuroendocrinology; 1993 Sep; 58(3):280-6. PubMed ID: 7902959
[TBL] [Abstract][Full Text] [Related]
15. The effects of chronic ethanol consumption on the mesolimbic and nigrostriatal dopamine systems.
Pellegrino SM; Druse MJ
Alcohol Clin Exp Res; 1992 Apr; 16(2):275-80. PubMed ID: 1534209
[TBL] [Abstract][Full Text] [Related]
16. Sex-dimorphic psychomotor activation after perinatal exposure to (-)-delta 9-tetrahydrocannabinol. An ontogenic study in Wistar rats.
Navarro M; Rubio P; Rodríguez de Fonseca F
Psychopharmacology (Berl); 1994 Dec; 116(4):414-22. PubMed ID: 7701042
[TBL] [Abstract][Full Text] [Related]
17. Maternal high fat diet during the perinatal period alters mesocorticolimbic dopamine in the adult rat offspring: reduction in the behavioral responses to repeated amphetamine administration.
Naef L; Srivastava L; Gratton A; Hendrickson H; Owens SM; Walker CD
Psychopharmacology (Berl); 2008 Mar; 197(1):83-94. PubMed ID: 18004547
[TBL] [Abstract][Full Text] [Related]
18. Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain.
Bonnin A; de Miguel R; Castro JG; Ramos JA; Fernandez-Ruiz JJ
J Mol Neurosci; 1996; 7(4):291-308. PubMed ID: 8968950
[TBL] [Abstract][Full Text] [Related]
19. Sex differences in mesolimbic dopamine responses to ethanol and relationship to ethanol intake in rats.
Blanchard BA; Glick SD
Recent Dev Alcohol; 1995; 12():231-41. PubMed ID: 7624545
[TBL] [Abstract][Full Text] [Related]
20. Effects of perinatal exposure to delta 9-tetrahydrocannabinol on operant morphine-reinforced behavior.
González B; de Miguel R; Martín S; Pérez-Rosado A; Romero J; García-Lecumberri C; Fernández-Ruiz J; Ramos JA; Ambrosio E
Pharmacol Biochem Behav; 2003 Jun; 75(3):577-84. PubMed ID: 12895675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
